Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Metered dose inhaler vs updraft nebulisations: equivalent efficacies but inequivalent costs

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Metered dose inhaler vs updraft nebulisations: equivalent efficacies but inequivalent costs. Inpharma Wkly. 682, 4 (1989). https://doi.org/10.1007/BF03286153

    Download citation

    Keywords

    • Chronic Obstructive Pulmonary Disease
    • Terbutaline
    • Obstructive Lung Disease
    • Dose Inhaler
    • Beta Agonist